• 1
    Thompson W, Heaton K. Functional bowel disorders in apparently healthy people. Gastroenterology 1980; 79: 2838.
  • 2
    Drossman D, Sandler R, McKee D, Lovitz A. Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction. Gastroenterology 1982; 83: 52934.
  • 3
    Sonnenberg A, Koch T. Physician visits in the United States for constipation. Dig Dis Sci 1986; 34: 60111.
  • 4
    Everhart J, Go V, Johannes R, et al. A longitudinal survey of self-reported bowel habits in the United States. Dig Dis Sci 1989; 34: 113462.
  • 5
    Lennard-Jones JE. Clinical classification of constipation. In: Kamm M, Lenard-Jones JE, eds. Constipation. Petersfield, Hampshire: Wrightson Biomedical, 1994: 3–10.
  • 6
    Gattuso JM, Kamm M. Review article: the management of constipation in adults. Aliment Pharmacol Ther 1993; 7: 84750.
  • 7
    Briejer MR, Schuurkes JAJ, Sarna SK. Idiopathic constipation: too few stools and too little knowledge. Trends Pharmacol Sci 1999; 20: 13.
  • 8
    Basotti G, Gaburri M, Imbimbo B, et al. Colonic mass movements in idiopathic chronic constipation. Gut 1988; 29: 11739.
  • 9
    Bouras EP, Camilleri M, Burton DD, McKinzie S. Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans. Gut 1999; 44 (5): 6826.
  • 10
    Emmanuel AV, Kamm MA, Roy AJ, Antonelli K. Effect of a novel prokinetic drug, R093877, on gastrointestinal transit in healthy volunteers. Gut 1998; 42: 5116.
  • 11
    Poen AC, Felt-Bersma RJ, Van Dongen PA, Meuwissen SG. Effect of prucalopride, a new enterokinetic agent, on gastrointestinal transit and anorectal function in healthy volunteers. Aliment Pharmacol Ther 1999; 13 (11): 14937.
  • 12
    Briejer M, Meulemans A, Bosmans J-P, Van Daele P, Schuurkes J. In vitro pharmacology of the novel enterokinetic R093877. Gastroenterology 1997; 112: A705A705(Abstract).
  • 13
    Briejer MR, Akkermans LMA, Schuurkes JAJ. Gastrointestinal prokinetic benzamides: the pharmacology underlying stimulation of motility. Pharmacol Rev 1995; 47: 63151.
  • 14
    Grider JR, Foxx-Orenstein AE, Jin J-G. 5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat and guinea pig intestine. Gastroenterology 1998; 115: 37080.
  • 15
    Briejer MR, Meulemans AL, Van Daele P, et al. R093877 induces giant migrating contractions (GMC) and alters colonic motility patterns in awake dogs. Neurogastroenterol Motil 1998; 10: 6262(Abstract).
  • 16
    Metcalf A, Philips S, Zinsmeister A, et al. Simplified assessment of segmental colonic transit. Gastroenterology 1987; 92: 407.
  • 17
    Arhan P, Devroede G, Jehannin B. Segmental colonic transit time. Dis Colon Rectum 1981; 24: 6259.
  • 18
    Cummings J, Wiggins H. Transit time through the gut, measured by analysis of a single stool. Gut 1976; 17: 21923.
  • 19
    Poen AC, De Brauw LM, Felt-Bersma RJF, De Jong D, Cuesta MA. Laparoscopic rectopexy for complete rectal prolapse. Clinical outcome and anorectal function tests. Surg Endosc 1996; 10: 9048.
  • 20
    Felt-Bersma RJF, Poen AC, Cuesta MA, Meuwissen SGM. Anal sensitivity test: what does it measure and do we need it? Cause or derivative of anorectal complaints? Dis Colon Rectum 1997; 40: 8116.
  • 21
    Drossman DA, Funch-Jensen P, Janssen J, Talley NJ, Thompson WG, Whitehead WE. Identification of subgroups of irritable bowel disorders. Gastroenterol Int 1990; 3: 15972.
  • 22
    Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ. Functional constipation and outlet delay: a population-based study. Gastroenterology 1993; 105: 78190.
  • 23
    Stewart WF, Liberman JN, Sandler RS, et al. Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features. Am J Gastroenterol 1999; 94: 353040.
    Direct Link:
  • 24
    Drossman DA. Idiopathic constipation: definition, epidemiology and behavioral aspects. In: Kamm MA, Lennard-Jones JE, eds. Constipation, 1st edn. Hampshire: Wrightson Biomedical Publishing Ltd, 1994: 11–17.
  • 25
    Sandler RS, Drossman D. Bowel habits in young adults not seeking health care. Dig Dis Sci 1987; 32: 8415.
  • 26
    Heaton KW, Radvan J, Cripps H, et al. Defecation frequency and timing, and stool form in the general population: a prospective study. Gut 1992; 33: 81824.
  • 27
    Mannaert E, Van Bortel L, Woestenborghs R, Van Peer A. Single-dose and once-daily pharmacokinetics and effects of food on prucalopride in humans. Gut 1999; 45(Suppl. V): P0252P0252(Abstract).
  • 28
    Van't Klooster G, De Pauw M, Crabbé R. Tolerability, pharmacokinetics and pharmacodynamics of prucalopride in healthy volunteers. Gut 1999; 45(Suppl. V): P0264P0264 (Abstract).
  • 29
    Felt-Bersma RJF, Bouchoucha M, Wurzer H, et al. Effects of a new enterokinetic drug, prucalopride, on symptoms of patients with chronic constipation: a double-blind, placebo-controlled, multicenter study in Europe. Gastroenterology 1999; 116(4 Part 2): A992A992(Abstract).
  • 30
    Coremans G, Kerstens R, De Pauw M, Stevens M. Effects of a new enterokinetic drug, prucalopride, on symptoms of patients with severe chronic constipation: a double-blind, placebo-controlled pilot study. Gastroenterology 1999; 116(4 Part 2): A978A978(Abstract).
  • 31
    Miner PB Jr, Nichols T, Silvers DR, Joslyn A, Woods M. The efficacy and safety of prucalopride in patients with chronic constipation. Gastroenterology 1999; 116(4 Part 2): A1043A1043(Abstract).
  • 32
    Emmanuel AV, Nicholls TJ, Roy AJ, et al. Prucalopride (PRU) improves colonic transit and stool frequency in patients with slow and normal transit constipation. Gastroenterology 2000; 118(4 Part 2): A846A846(Abstract).
  • 33
    Vandeplassche G, Crabbé R, De Smedt H, Podoor M, Lauwers LF. A placebo-controlled study to evaluate the effects of single increasing oral doses of R093877 (R) on bowel habit, safety and tolerability in healthy volunteers. Gastroenterology 1997; 112(4 Part 2): A843A843(Abstract).
  • 34
    Hagger R, Benson M, Lloyd R, et al. A placebo-controlled study to evaluate the effect on colonic transit of R093877 in healthy volunteers. Gastroenterology 1998; 114(4 Part 2): A759A759(Abstract).